[Endogenic infectious diseases and and prospects of their treatment].
D000328:Adult; D001424:Bacterial Infections / Q000188:drug therapy*; D001688:Biological Products / Q000627:therapeutic use*; D003165:Complement System Proteins / Q000032:analysis; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy*; D005260:Female; D006506:Hepatitis A / Q000188:drug therapy*; D006801:Humans; D007422:Intestines / Q000382:microbiology; D007962:Leukocytes / Q000032:analysis; D008875:Middle Aged; D009113:Muramidase / Q000097:blood / Q000627:therapeutic use*; D011353:Prodigiosin / Q000627:therapeutic use*; D018805:Sepsis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*
D001688:Biological Products; D003165:Complement System Proteins; D009113:Muramidase; D011353:Prodigiosin
Endogennye infektsionnye zabolevaniia i perspektiva ikh lecheniia